Julia E. Vertrees

2.5k total citations
22 papers, 1.1k citations indexed

About

Julia E. Vertrees is a scholar working on Pharmacology, Clinical Psychology and Psychiatry and Mental health. According to data from OpenAlex, Julia E. Vertrees has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Clinical Psychology and 7 papers in Psychiatry and Mental health. Recurrent topics in Julia E. Vertrees's work include Treatment of Major Depression (6 papers), Bipolar Disorder and Treatment (5 papers) and Schizophrenia research and treatment (4 papers). Julia E. Vertrees is often cited by papers focused on Treatment of Major Depression (6 papers), Bipolar Disorder and Treatment (5 papers) and Schizophrenia research and treatment (4 papers). Julia E. Vertrees collaborates with scholars based in United States, Vietnam and Singapore. Julia E. Vertrees's co-authors include Robert A. Rosenheck, Daniel M. Canafax, Robert J. Cipolle, Donald L. Uden, Richard M. Rosenfeld, G. Scott Giebink, John H. Krystal, James L. Carr, Philip W. Lavori and Grant D. Huang and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Julia E. Vertrees

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia E. Vertrees United States 13 285 249 245 199 184 22 1.1k
Robert L. Williams United States 18 211 0.7× 89 0.4× 239 1.0× 106 0.5× 358 1.9× 39 1.3k
Macey L. Murray United Kingdom 23 960 3.4× 347 1.4× 177 0.7× 69 0.3× 108 0.6× 47 1.9k
Cristina Russ United States 17 74 0.3× 119 0.5× 149 0.6× 267 1.3× 159 0.9× 56 1.8k
Tjalling W. de Vries Netherlands 24 237 0.8× 114 0.5× 100 0.4× 33 0.2× 398 2.2× 89 1.5k
N. Virgili Spain 18 42 0.1× 187 0.8× 71 0.3× 62 0.3× 117 0.6× 55 1.2k
Natalie Riblet United States 15 83 0.3× 303 1.2× 65 0.3× 86 0.4× 95 0.5× 68 869
Chantal Guímont Canada 19 401 1.4× 54 0.2× 219 0.9× 111 0.6× 220 1.2× 39 1.5k
Chunsong Yang China 18 261 0.9× 216 0.9× 118 0.5× 56 0.3× 68 0.4× 80 953
Mohammadreza Hajiesmaeili Iran 20 50 0.2× 177 0.7× 98 0.4× 67 0.3× 64 0.3× 95 1.1k
Pamela Sullivan United States 4 75 0.3× 62 0.2× 100 0.4× 49 0.2× 159 0.9× 4 1.0k

Countries citing papers authored by Julia E. Vertrees

Since Specialization
Citations

This map shows the geographic impact of Julia E. Vertrees's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia E. Vertrees with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia E. Vertrees more than expected).

Fields of papers citing papers by Julia E. Vertrees

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia E. Vertrees. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia E. Vertrees. The network helps show where Julia E. Vertrees may publish in the future.

Co-authorship network of co-authors of Julia E. Vertrees

This figure shows the co-authorship network connecting the top 25 collaborators of Julia E. Vertrees. A scholar is included among the top collaborators of Julia E. Vertrees based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia E. Vertrees. Julia E. Vertrees is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hicks, Paul B., Varadan Sevilimedu, Gary R. Johnson, et al.. (2023). Factors Affecting Antidepressant Response Trajectories: A Veterans Affairs Augmentation and Switching Treatments for Improving Depression Outcomes Trial Report. SHILAP Revista de lepidopterología. 5(4). 131–143. 1 indexed citations
2.
Zisook, Sidney, Gary R. Johnson, Ilanit Tal, et al.. (2019). General Predictors and Moderators of Depression Remission: A VAST-D Report. American Journal of Psychiatry. 176(5). 348–357. 31 indexed citations
3.
Belitskaya‐Lévy, Ilana, Maurice W. Dysken, Peter Guarino, et al.. (2018). Impact of apolipoprotein E genotypes on vitamin E and memantine treatment outcomes in Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 4(1). 344–349. 9 indexed citations
4.
Sather, Mike R., Kathy D. Boardman, Stuart Warren, et al.. (2017). Total integrated performance excellence system (TIPES): A true north direction for a clinical trial support center. Contemporary Clinical Trials Communications. 9. 81–92.
5.
Zisook, Sidney, Ilanit Tal, Kimberly Weingart, et al.. (2016). Characteristics of U.S. Veteran Patients with Major Depressive Disorder who require “next-step” treatments: A VAST-D report. Journal of Affective Disorders. 206. 232–240. 17 indexed citations
6.
Krystal, John H., Robert H. Pietrzak, Robert A. Rosenheck, et al.. (2016). Sleep Disturbance in Chronic Military-Related PTSD. The Journal of Clinical Psychiatry. 77(4). 483–491. 30 indexed citations
7.
Guarino, Peter, Julia E. Vertrees, Sanjay Asthana, et al.. (2016). Measuring informed consent capacity in an Alzheimer's disease clinical trial. Alzheimer s & Dementia Translational Research & Clinical Interventions. 2(4). 258–266. 10 indexed citations
8.
Weinstock, Martin A., Stephen F. Bingham, John J. DiGiovanna, et al.. (2012). Tretinoin and the Prevention of Keratinocyte Carcinoma (Basal and Squamous Cell Carcinoma of the Skin): A Veterans Affairs Randomized Chemoprevention Trial. Journal of Investigative Dermatology. 132(6). 1583–1590. 72 indexed citations
9.
Rosenheck, Robert A., John H. Krystal, Robert Lew, et al.. (2011). Long-Acting Risperidone and Oral Antipsychotics in Unstable Schizophrenia. New England Journal of Medicine. 364(9). 842–851. 171 indexed citations
10.
Krystal, John H., Robert A. Rosenheck, Joyce A. Cramer, et al.. (2011). Adjunctive Risperidone Treatment for Antidepressant-Resistant Symptoms of Chronic Military Service–Related PTSD. JAMA. 306(5). 493–493. 150 indexed citations
11.
Rosenheck, Robert A., John H. Krystal, Robert Lew, et al.. (2011). Challenges in the design and conduct of controlled clinical effectiveness trials in schizophrenia. Clinical Trials. 8(2). 196–204. 6 indexed citations
12.
Krystal, John H., Robert A. Rosenheck, Joyce A. Cramer, et al.. (2011). Adjunctive Risperidone Treatment for Antidepressant-Resistant Symptoms of Chronic Military Service-Related PTSD. 11 indexed citations
13.
Matchar, David B., Alan K. Jacobson, Rowena J Dolor, et al.. (2010). Effect of Home Testing of International Normalized Ratio on Clinical Events. New England Journal of Medicine. 363(17). 1608–1620. 170 indexed citations
14.
Dolor, Rowena J, Lauren Uyeda, Robert Edson, et al.. (2010). An evaluation of patient self-testing competency of prothrombin time for managing anticoagulation: pre-randomization results of VA Cooperative Study #481–The Home INR Study (THINRS). Journal of Thrombosis and Thrombolysis. 30(3). 263–275. 18 indexed citations
15.
McFall, Miles, Andrew J. Saxon, Mark W. Smith, et al.. (2007). Integrating smoking cessation into mental health care for post-traumatic stress disorder. Clinical Trials. 4(2). 178–189. 34 indexed citations
16.
Sajatovic, Martha, Mark S. Bauer, Amy M. Kilbourne, Julia E. Vertrees, & William O. Williford. (2006). Self-Reported Medication Treatment Adherence Among Veterans With Bipolar Disorder. Psychiatric Services. 57(1). 56–62. 70 indexed citations
17.
Matchar, David B., Alan K. Jacobson, Robert Edson, et al.. (2005). The Impact of Patient Self-Testing of Prothrombin Time for Managing Anticoagulation: Rationale and Design of VA Cooperative Study #481—The Home INR Study (THINRS). Journal of Thrombosis and Thrombolysis. 19(3). 163–172. 22 indexed citations
18.
Alfaro, Cara L., et al.. (2001). Unanticipated Plasma Concentrations in Two Clozapine-Treated Patients. Annals of Pharmacotherapy. 35(9). 1028–1031. 4 indexed citations
19.
Rosenfeld, Richard M., Julia E. Vertrees, James L. Carr, et al.. (1994). Clinical efficacy of antimicrobial drugs for acute otitis media: Metaanalysis of 5400 children from thirty-three randomized trials. The Journal of Pediatrics. 124(3). 355–367. 273 indexed citations
20.
Vertrees, Julia E., Bennie McWilliams, & H. William Kelly. (1990). Repeated Oral Administration of Activated Charcoal for Treating Aspirin Overdose in Young Children. PEDIATRICS. 85(4). 594–598. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026